1-6 of 6
Angela Lopez
Close
Sort by
Journal Articles

Treatment with Romiplostim, a Thrombopoietin-Receptor Agonist, in Thrombocytopenic Patients (Pts) with Low or Intermediate-1 (Int-1) Risk Myelodysplastic Syndrome (MDS): Updated Follow-up Results for Acute Myeloid Leukemia (AML) and Survival from a Randomized, Double-Blind, Placebo (PBO)-Controlled Study

Hagop M. Kantarjian, Ghulam Mufti, Pierre Fenaux, Mikkael Sekeres, Jeffrey Szer, Uwe Platzbecker, Andrea Kuendgen, MD, Gianluca Gaidano, Wieslaw Wiktor-Jedrzejczak, Amelia Orejudos, Angela Lopez, Aristoteles Giagounidis
Journal: Blood
Blood (2014) 124 (21): 3276.
https://doi.org/10.1182/blood.V124.21.3276.3276
Published: 2014
Journal Articles

Final Results from a Phase 4 Open-Label 3-Year Study Evaluating Changes in Bone Marrow (Bm) Morphology in Adult Immune Thrombocytopenia (ITP) Patients (Pts) Receiving the Thrombopoietin Mimetic Romiplostim

Ann Janssens, Francesco Rodeghiero, David Anderson, Beng Chong, Zoltan Boda, Ingrid Pabinger, Libor Cervinek, MD PhD, Xuena Wang, Angela Lopez
Journal: Blood
Blood (2014) 124 (21): 2774.
https://doi.org/10.1182/blood.V124.21.2774.2774
Published: 2014
Journal Articles

A Final Analysis of a Phase 2, Single-Arm Study of Platelet (Plt) Responses and Remission Rates in Patients with Immune Thrombocytopenia (ITP) Receiving Romiplostim

Adrian Newland, Bertrand Godeau, Victor Priego, Jean-Francois Viallard, Maria Fernanda Lopez Fernandez, Amelia Orejudos, Angela Lopez
Journal: Blood
Blood (2014) 124 (21): 2775.
https://doi.org/10.1182/blood.V124.21.2775.2775
Published: 2014
Journal Articles

Treatment With Romiplostim, a Thrombopoietin-Receptor Agonist, In Thrombocytopenic Patients With Low Or Intermediate-1 Risk Myelodysplastic Syndrome: Updated Follow-Up Results For Acute Myeloid Leukemia and Survival From a Randomized, Double-Blind, Placebo-Controlled Study

Hagop M. Kantarjian, MD, Ghulam J. Mufti, MD, PhD, Pierre Fenaux, MD, PhD, Mikkael A. Sekeres, MD, MS, Jeffrey Szer, MBBS, Uwe Platzbecker, MD, PhD, Andrea Kuendgen, MD, Gianluca Gaidano, Wieslaw Wiktor-Jedrzejczak, Anne Meibohm, PhD, Angela Lopez, Aristoteles Giagounidis, MD
Journal: Blood
Blood (2013) 122 (21): 1553.
https://doi.org/10.1182/blood.V122.21.1553.1553
Published: 2013
Journal Articles

Results From a Phase IV Open-Label Study Evaluating Changes In Bone Marrow Morphology In Adult Immune Thrombocytopenia (ITP) Patients Receiving Romiplostim: Analysis Of The 1- and 2-Year Romiplostim Cohorts

Ann Janssens, MD, Francesco Rodeghiero, David Anderson, Beng Chong, MBBS FRCPA FRACP PhD, Zoltan Boda, Ingrid Pabinger, Libor Cervinek, Xuena Wang, Angela Lopez
Journal: Blood
Blood (2013) 122 (21): 2312.
https://doi.org/10.1182/blood.V122.21.2312.2312
Published: 2013
Journal Articles

An Interim Analysis Of a Phase 2, Single-Arm Study Of Platelet Responses and Remission Rates In Patients With Immune Thrombocytopenia (ITP) Receiving Romiplostim

Roberto Stasi, MD, PhD, Adrian Newland, Bertrand Godeau, Victor Priego, MD, Jean-Francois Viallard, Maria Fernanda Lopez Fernandez, Catherine Jia, Angela Lopez
Journal: Blood
Blood (2013) 122 (21): 1074.
https://doi.org/10.1182/blood.V122.21.1074.1074
Published: 2013